Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT
Status:
Recruiting
Trial end date:
2023-04-14
Target enrollment:
Participant gender:
Summary
Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis,
and Coronavirus Disease 2019 with [18F]FP-R01-MG-F2 with PET/CT